Keren Levanon
Impact in
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Renal and related cancers 3
-
- Ovarian cancer diagnosis and treatment 13
- Co-authors
- Ronny Drapkin (7 shared papers)Christopher P. Crum (1 shared paper)Alison M. Karst (2 shared papers)Michelle S. Hirsch (3 shared papers)Iris Barshack (8 shared papers)Myung Hwan Roh (2 shared papers)Keren Bahar‐Shany (7 shared papers)Yi Zhang (1 shared paper)
- Journals
- Oncogene (5 papers)Gynecologic Oncology (3 papers)Neoplasia (2 papers)Journal of Clinical Investigation (2 papers)Journal of Visualized Experiments (2 papers)
- Partner nations
- IsraelUnited StatesItaly
In The Last Decade
Keren Levanon
30 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 87
- Reproductive Medicine 639
- Cancer Research 313
- Obstetrics and Gynecology 159
- Oncology 329
- Immunology 169
Countries citing papers authored by Keren Levanon
This map shows the geographic impact of Keren Levanon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keren Levanon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keren Levanon more than expected).
Fields of papers citing papers by Keren Levanon
This network shows the impact of papers produced by Keren Levanon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keren Levanon. The network helps show where Keren Levanon may publish in the future.
Co-authors
The 25 scholars most cited alongside Keren Levanon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 298 | |
| 2 | 2011 | 216 | |
| 3 | 2009 | 162 | |
| 4 | 2013 | 72 | |
| 5 | 2011 | 71 | |
| 6 | 2001 | 62 | |
| 7 | 2004 | 40 | |
| 8 | 2005 | 39 | |
| 9 | 2015 | 38 | |
| 10 | 2004 | 35 | |
| 11 | 2018 | 35 | |
| 12 | 2020 | 35 | |
| 13 | 2019 | 27 | |
| 14 | 2011 | 24 | |
| 15 | 2013 | 24 | |
| 16 | 2023 | 22 | |
| 17 | 2016 | 21 | |
| 18 | 2018 | 17 | |
| 19 | 2006 | 16 | |
| 20 | 2017 | 14 |
About Keren Levanon
Keren Levanon is a scholar working on Molecular Biology, Reproductive Medicine, Oncology, Cancer Research and Public Health, Environmental and Occupational Health, having authored 31 papers that have together received 1.3k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (13 papers), Reproductive Biology and Fertility (6 papers), Reproductive System and Pregnancy (4 papers), Breast Cancer Treatment Studies (3 papers), Renal and related cancers (3 papers), Virus-based gene therapy research (3 papers), Peptidase Inhibition and Analysis (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Reproductive Medicine (639 citations), Cancer Research (313 citations), Obstetrics and Gynecology (159 citations), Oncology (329 citations) and Immunology (169 citations). Keren Levanon has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Ronny Drapkin, Christopher P. Crum, Alison M. Karst, Michelle S. Hirsch, Iris Barshack, Myung Hwan Roh, Keren Bahar‐Shany, Yi Zhang, David W. Kindelberger and Jarrod A. Marto. Their work appears in journals such as Oncogene, Gynecologic Oncology, Neoplasia, Journal of Clinical Investigation and Journal of Visualized Experiments.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.